Trial
NCT01957709
Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI); Horizon Pharma USA, Inc.
Condition
Myxoid Liposarcoma
Intervention
Laboratory Biomarker Analysis
Why stopped
Enough samples were collected for data analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-07-10